טוען...
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
Warfarin is primarily metabolized by cytochrome 2C9, encoded by gene CYP2C9. Here, we investigated whether variants in nuclear receptor genes which regulate the expression of CYP2C9 are associated with warfarin response. We used data from 906 warfarin users from the Quebec Warfarin Cohort (QWC) and...
שמור ב:
| הוצא לאור ב: | Pharmacogenomics J |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group UK
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6462825/ https://ncbi.nlm.nih.gov/pubmed/29298995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41397-017-0005-1 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|